MedTrace Logo

Depression Treatment and Risk for Cardiovascular Disease

NCT06170255 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2023-12-14

No results posted yet for this study

Summary

This study was designed to determine the feasibility of a Randomized Controlled Trial (RCT) that involved treating depression among participants with an elevated risk for cardiovascular disease. It is expected that treating depression through non-pharmacological means will impact heart rate variability, a proximal measure of CVD risk.

Conditions

Interventions

BEHAVIORAL

Behavioral Activation (BA)

Behavioral activation involves an exploration of the patient's individualized values and follows with goal setting to improve depression symptoms.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • East Carolina University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-06
Primary Completion
2017-10-02
Completion
2017-10-02

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06170255 on ClinicalTrials.gov